Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone
about
The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor functionAGEs induce ectopic endochondral ossification in intervertebral discsChronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice.Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and riboseCirculating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health StudyAssociation between non-enzymatic glycation, resorption, and microdamage in human tibial cortices.Exercise increases pyridinoline cross-linking and counters the mechanical effects of concurrent lathyrogenic treatment.Multiscale Predictors of Femoral Neck In Situ Strength in Aging Women: Contributions of BMD, Cortical Porosity, Reference Point Indentation, and Nonenzymatic Glycation.Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.Determinants of bone strength and quality in diabetes mellitus in humans.Bone quality in diabetes.Bone mechanical properties and changes with osteoporosis.Presence of pyrophosphate in bone from an atypical femoral fracture site: A case report.Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease.Bone Material Properties and Skeletal Fragility.Bone Material Properties in Osteogenesis Imperfecta.Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells.Changes in the Fracture Resistance of Bone with the Progression of Type 2 Diabetes in the ZDSD Rat.Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties.Luteolin alleviates methylglyoxal-induced cytotoxicity in osteoblastic MC3T3-E1 cells.Bone tissue collagen maturity and mineral content increase with sustained hyperglycemia in the KK-Ay murine model of type 2 diabetes.Rapid Non-Enzymatic Glycation of the Insulin Receptor under Hyperglycemic Conditions Inhibits Insulin Binding In Vitro: Implications for Insulin Resistance.Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration.Age-Related Effects of Advanced Glycation End Products (Ages) in Bone Matrix on Osteoclastic Resorption.Accumulation of carboxymethyl-lysine (CML) in human cortical bone.Bone Formation is Affected by Matrix Advanced Glycation End Products (AGEs) In Vivo.Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/β-catenin signaling in mice.The Role of Matrix Composition in the Mechanical Behavior of Bone.Altered bone material properties in HLA-B27 rats include reduced mineral to matrix ratio and altered collagen cross-links.Soy protein improves tibial whole-bone and tissue-level biomechanical properties in ovariectomized and ovary-intact, low-fit female rats.
P2860
Q26767495-CED84EC7-5163-4159-AA36-7B4CE9281D26Q33828356-1AB1942B-812A-4341-806C-E65ED627FDDEQ35068710-AF709F89-DDDD-4187-A8FC-CF242DCF1785Q35101624-E8299C3F-AF12-44B0-B719-956AA4197D61Q35911173-C917E4E3-665D-430E-817B-12ED6B7A8761Q36010491-E9BF307A-D919-417B-8EC4-6E598F8A4F53Q36269087-6DF64E3C-B213-41A9-B20C-A621F5D590BCQ36355576-D06F6A6D-B0E4-4F44-83D8-0CF6CB7B3E08Q36372679-7233597D-0046-4AA5-9408-2FC852DE3C21Q36373016-C32244AB-D4FB-4FB3-9ED2-020D83AEBAAEQ36927957-7C21C293-1741-4930-8334-CB75C9B95AEBQ37113961-2079A2CD-B7B9-4B99-B142-B5EED5EB0A01Q37720674-C2176CCC-06A0-4CD9-A8F0-A0AA0E572E48Q38384409-FC9A48E4-A45E-48F3-BAE4-CDAB3BA7F9B5Q38458050-8EF2A595-2E05-4ED7-87A8-B86773F0ABA5Q38778771-48CB51EB-5D96-40E2-8F80-08155DE1B718Q38811614-70396402-153F-4888-91E0-41DF5833CECBQ42402817-98505264-112B-44FA-BDC6-92EA81996FC8Q43689965-5BD5161F-106D-42D9-98B1-9BB9D45F7F66Q44691601-5A9BD1FF-6FB6-483A-B120-957E26157AD7Q47216121-055FAC0D-0F79-43A1-96D5-197AFBE234ABQ47273723-5AC44074-BEE2-4886-8C81-35A85B0AAC59Q47962287-7D01396D-D046-4421-AC7B-F55D6150C801Q48155040-91757A51-02C5-4A83-8607-EF412A641D3CQ50058403-25DAEA3B-E5A7-436C-A856-2E618A3903FBQ51311945-BCC8A052-462C-4D74-A9CB-6D9D1673263EQ51701297-16BC4594-43AA-4DCC-80AC-BE2740EA5A64Q53699099-AAE79253-6FC3-40E7-B380-923920D679EDQ54474275-A227BB75-0818-44C5-9F90-BCE2B4D3ADC5Q55359589-8907CD45-E54E-4E2D-ADBC-6579B076AFF8
P2860
Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Differences in non-enzymatic g ...... n cortical and cancellous bone
@ast
Differences in non-enzymatic g ...... n cortical and cancellous bone
@en
type
label
Differences in non-enzymatic g ...... n cortical and cancellous bone
@ast
Differences in non-enzymatic g ...... n cortical and cancellous bone
@en
prefLabel
Differences in non-enzymatic g ...... n cortical and cancellous bone
@ast
Differences in non-enzymatic g ...... n cortical and cancellous bone
@en
P2093
P2860
P1476
Differences in non-enzymatic g ...... n cortical and cancellous bone
@en
P2093
P2860
P2888
P304
P356
10.1007/S00198-013-2319-4
P407
P577
2013-03-08T00:00:00Z